RT Journal Article
SR Electronic
T1 582 Analysis of the HR+/HER2- breast cancer tumor microenvironment following immune priming with pelareorep and atezolizumab using imaging mass cytometry – Results from the AWARE-1 trial
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A662
OP A662
DO 10.1136/jitc-2023-SITC2023.0582
VO 11
IS Suppl 1
A1 Olea, Julian
A1 Dadrastoussi, Homa
A1 Hernandez, Eduardo Fernandez
A1 Martinez, Hugo Lara
A1 Wu, Kaijin
A1 Loghmani, Houra
A1 Heineman, Thomas
A1 Trauger, Richard
A1 Coffey, Matt
A1 Salvador, Fernando
A1 Gavilá, Joaquín
A1 Pascual, Tomás
A1 Manso, Luis
A1 Prat, Aleix
A1 Merchant, Akil
A1 Kelly, Kevin
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A662.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.